SeaSpine Launches Shoreline RT Cervical Interbody Implant System

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch and completion of the first surgery for its Shoreline RT Cervical Interbody Implant System. Shoreline RT represents the first in a series of products that will marry the company’s proprietary NanoMetalene technology with Reef Topography. The company anticipates launching five additional products with NanoMetalene technology and Reef Topography by the end of 2020.
 
Reef Topography describes machined macrostructures and undercut features that are designed to act as an integrated fusion scaffolding that enhance the company’s proprietary NanoMetalene surface technology. Reef Topography provides an innovative structure with increased surface area for new bone to grow onto and into the implant. For example, Shoreline RT provides more than 40 percent increased endplate surface area versus Shoreline without Reef Topography.
 
“We believe the Shoreline RT launch represents a significant advancement in interbody technology that addresses the growing demand for implants that have the potential to reduce the use of high-cost orthobiologics during interbody fusion procedures,” stated Shaeffer Bannigan, Director of Product Development. “This new technology, along with products within our complementary orthobiologics portfolio, such as Strand and Strand Plus demineralized bone fibers, supports our mission to maximize clinical value by developing cost-effective solutions to treat spinal disorders.”
 
Shoreline RT is designed to be used in ACDF (anterior cervical discectomy fusion) procedures as part of the company’s Shoreline ACS System or in combination with its Cabo™ anterior cervical plate. The Shoreline ACS System includes implants with large footprints and multiple lordosis options designed to allow surgeons to address a variety of pathologies and patient anatomies.
 
“In prioritizing value-based care for our patients, it is critical that we work with companies, like SeaSpine, to create novel procedural technologies aimed at providing more cost-effective solutions and better surgical outcomes,” said Dr. Robert Eastlack, Department of Orthopaedic Surgery, Scripps Clinic.